Description of the first genetically confirming case with Donahue’s syndrome in Russia

2016 ◽  
Vol 62 (2) ◽  
pp. 42-45
Author(s):  
Yulia V. Tikhonovich ◽  
Oleg A. Malievsky ◽  
Anatoly Tyul'pakov

Syndrome Donahue (leprechaunism) is a rare form of neonatal diabetes mellitus associated with INSR gene mutations. There are three types of insulin resistance syndrome: Donohue syndrome, Rabson—Mendenhall syndrome and insulin resistance type A. These syndromes are distinguished from one another by severity of symptoms, age of onset and age of death. Donohue and Rabson—Mendenhall syndromes are associated with biallelic mutations in the α-subunit or/and β-subunit of INSR gene and are characterized by more severe phenotype and poor prognosis. Patients with Donohue syndrome usually die within the first two years of life. Life expectancy of patients with Rabson—Mendenhall syndrome is 5—15 years. Most patients with insulin resistance type A have heterozygous mutations in the β-subunit and demonstrate mild phenotype. Here, we describe the first genetically confirmed case of syndrome Donahue in the Russian Federation.

Author(s):  
Elaine E Sanderson ◽  
Mark Shah ◽  
Amanda J Hooper ◽  
Damon A Bell ◽  
Catherine S Choong

Summary We report a case of an 11-year-old girl presenting with a new diagnosis of diabetes associated with a heterozygous missense mutation in the insulin receptor (INSR) gene. This case highlights that INSR gene variants can be a cause for monogenic diabetes in children and adolescents and the need for genetic evaluation in atypical presentations of diabetes. We also describe the possible role of metformin in treating individuals with type A insulin resistance syndrome due to INSR gene variants. Learning points Insulin receptor (INSR) gene variants can be a cause of monogenic diabetes in children and adolescents. Genetic evaluation should be considered in children and adolescents with type 2 diabetes (T2D), particularly where there is an atypical presentation and/or positive family history. Metformin may have a role in the treatment of type A insulin resistance syndrome due to heterozygous mutation of the INSR gene.


Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1748-P
Author(s):  
AMMIRA S. AKIL ◽  
ESRAA A.M. YASSIN ◽  
SUJITHA SUBASH PADMAJEYA ◽  
LAILA A. JERMAN ◽  
ABEER FADDA ◽  
...  

2018 ◽  
Author(s):  
Arameh Aghababaie ◽  
Martha Ford-Adams ◽  
Charles R Buchanan ◽  
Ved Arya ◽  
Andrew Hattersley ◽  
...  

The Lancet ◽  
1994 ◽  
Vol 343 (8905) ◽  
pp. 1073-1074 ◽  
Author(s):  
S. Kumar ◽  
P.N. Durrington ◽  
D. Bhatnagar ◽  
I. Laing

2020 ◽  
Vol 8 (15) ◽  
pp. 3334-3340
Author(s):  
Fang-Fang Yan ◽  
Bing-Kun Huang ◽  
Yin-Ling Chen ◽  
Yan-Zhen Zhuang ◽  
Xue-Ye You ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document